phrykt

Johnson & Johnson (JNJ) cash: $19.7B

Johnson & Johnson held $19.7B in cash and cash equivalents on Dec 28, 2025, down 18.2% from $24.1B a year earlier.

From Johnson & Johnson's filings with the SEC · Read the filing · JNJ stock page

Johnson & Johnson cash by year

$14.5B2021$12.9B2022$21.9B2023$24.1B2024$19.7B2025

#23 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 28, 2025$19.7B-18%
Dec 29, 2024$24.1B+10%
Dec 31, 2023$21.9B+70%
Jan 1, 2023$12.9B-11%
Jan 2, 2022$14.5B–

Cash of similar companies

Companies in the same industry as Johnson & Johnson, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
Johnson & Johnson$19.7BDec 28, 2025
Merck$14.6BDec 31, 2025
Bristol Myers Squibb$10.2BDec 31, 2025
Abbott Laboratories$8.5BDec 31, 2025
Eli Lilly$7.3BDec 31, 2025
AbbVie$5.2BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$5.1BDec 31, 2025

Questions and answers

What is Johnson & Johnson's cash?

Johnson & Johnson held $19.7B in cash and cash equivalents on Dec 28, 2025, down 18.2% from $24.1B a year earlier.

Numbers as reported in Johnson & Johnson's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology